<DOC>
	<DOCNO>NCT01144039</DOCNO>
	<brief_summary>Purpose : The effect intravenous glutamate infusion myocardial diastolic function overall hemodynamics study patient undergo elective aortic valve replacement severe aortic stenosis associate leave ventricular hypertrophy . Methods : 25 patient include double-blind randomize placebo-controlled study . Glutamate administer intravenously immediately aortic cross-clamp release . The patient receive either low dose 30mg kg-1 h-1 ( LG-group ) high dose 60 mg kg-1 h-1 ( HG-group ) placebo ( P-group ) rate 3.3ml kg-1h-1 2h . Transesophageal echocardiography ( TEE ) use measure diastolic systolic ventricular function sternotomy ( T0 ) , 2h ( T2 ) , 3h ( T3 ) 6h ( T4 ) release cross clamp . Additionally routine hemodynamic parameter measure intraoperatively .</brief_summary>
	<brief_title>Glutamate Diastolic Function Patients Undergoing Aortic Valve Repair</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<criteria>severe aortic stenosis leave ventricular hypertrophy 10mm IVS thickness normal ejection fraction SR moderately severely reduce systolic leave ventricular function ( ejection fraction &lt; 30 % ) atrial fibrillation flutter intolerance glutamate .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>